Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'REOCCLUSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 236 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bauermeister, G
      Endovascular stent-grafting in the treatment of superficial femoral arteryocclusive disease

      JOURNAL OF ENDOVASCULAR THERAPY
    2. Scheinert, D; Laird, JR; Schroder, M; Steinkamp, H; Balzer, JO; Biamino, G
      Excimer laser-assisted recanalization of long, chronic superficial femoralartery occlusions

      JOURNAL OF ENDOVASCULAR THERAPY
    3. Van de Werf, F
      New aspects of pharmacological reperfusion: from macro- to microlysis

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Gershlick, AH
      Keeping the coronary arteries open: current opportunities

      HOSPITAL MEDICINE
    5. Guerrero, B; Arocha-Pinango, CL; Pinto, MA; Muller, CA; San Juan, AG; Amorim, S; Perales, J
      Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model

      BLOOD COAGULATION & FIBRINOLYSIS
    6. Gyongyosi, M; Wexberg, P; Kiss, K; Yang, P; Sperker, W; Sochor, H; Laggner, A; Glogar, D
      Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction

      CORONARY ARTERY DISEASE
    7. Scrutinio, D; Cimminiello, C; Marubini, E; Pitzalis, MV; Di Biase, M; Rizzon, P
      Ticlopidine versus aspirin after myocardial infarction (STAMI) trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    8. Grotta, JC; Welch, KMA; Fagan, SC; Lu, M; Frankel, MR; Brott, T; Levine, SR; Lyden, PD
      Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial

      STROKE
    9. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Konishi, N; Terashita, Z; Naka, T
      Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    10. Barbash, GI; Birnbaum, Y; Bogaerts, K; Hudson, M; Lesaffre, E; Fu, YL; Goodman, S; Houbracken, K; Munsters, K; Granger, CB; Pieper, K; Califf, RM; Topol, EJ; Van de Werf, F
      Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies

      CIRCULATION
    11. Gershlick, AH
      Antiplatelet therapy

      HOSPITAL MEDICINE
    12. Watson, HR; Bergqvist, D
      Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    13. Serebruany, VL; Lowry, DR; Fuzailov, SY; Levine, DJ; O'Connor, CM; Gurbel, PA
      Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    14. Vermeer, F; Vahanian, A; Fels, PW; Besse, P; Muller, E; Van de Werf, F; Fitzgerald, D; Darius, H; Puel, J; Garrigou, D; Simoons, ML
      Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    15. Waksman, R; Bhargava, B; Mintz, GS; Mehran, R; Lansky, AJ; Satler, LF; Pichard, AD; Kent, KM; Leon, MB
      Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    16. Qasim, A; Chauhan, A; More, RS
      Failed thrombolysis in myocardial infarction

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    17. Yoshino, H; Kachi, E; Shimizu, H; Taniuchi, M; Yano, K; Udagawa, H; Kajiwara, T; Shimoyama, K; Ishikawa, K
      Severity of residual stenosis of infarct-related lesion and left ventricular function after single-vessel anterior wall myocardial infarction: Implication of ST-segment elevation in lead aVL of the admission electrocardiograms

      CLINICAL CARDIOLOGY
    18. Li, M; Goto, S; Sakai, H; Kim, JY; Ichikawa, N; Yoshida, M; Ikeda, Y; Handa, S
      Enhanced shear-induced von Willebrand factor binding to platelets in acutemyocardial infarction

      THROMBOSIS RESEARCH
    19. Pakala, R; Liang, CT; Benedict, CR
      Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor

      THROMBOSIS RESEARCH
    20. Jackson, CV; Bailey, BD; Shetler, TJ
      Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. Peter, K; Kohler, B; Straub, A; Ruef, J; Moser, M; Nordt, T; Olschewski, M; Ohman, ME; Kubler, W; Bode, C
      Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine - Continuous platelet inhibition by the combination of abciximab and ticlopidine

      CIRCULATION
    22. Ragni, M; Golina, P; Cirillo, P; Scognamiglio, A; Piro, O; Esposito, N; Battaglia, C; Botticella, F; Ponticelli, P; Ramunno, L; Chiariello, M
      Endogenous tissue factor pathway inhibitor modulates thrombus formation inan in vivo model of rabbit carotid artery stenosis and endothelial injury

      CIRCULATION
    23. Zoldhelyi, P; McNatt, J; Shelat, HS; Yamamoto, Y; Chen, ZQ; Willerson, JT
      Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor

      CIRCULATION
    24. Armstrong, PW; Burton, JR; Palisaitis, D; Thompson, CR; Van de Werf, F; Rose, B; Collen, D; Teo, KK
      Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)

      AMERICAN HEART JOURNAL
    25. Theroux, P
      Antiplatelet drugs in the acute phase of myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    26. Astorri, E; Garini, A; Pedroni, G; Ferrari, O; Bonifazi, C
      Prediction of infarct-related coronary artery patency after thrombolytic therapy in acute myocardial infarction: Use of ST-segment as a non-invasive marker

      Journal of cardiovascular diagnosis and procedures
    27. Cohen, M
      Treatment of unstable angina: The role of platelet inhibitors and anticoagulants

      JOURNAL OF INVASIVE CARDIOLOGY
    28. Menown, IBA; Adgey, AAJ
      Improving reperfusion after myocardial infarction - Using glycoprotein IIb/IIIb antagonists as adjuncts to fibrinolytic therapy holds promise

      BRITISH MEDICAL JOURNAL
    29. Holper, EM; Giugliano, RP; Antman, EM
      Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction

      CORONARY ARTERY DISEASE
    30. Fox, KAA
      Have we reached the limit with thrombolytic therapy?

      CARDIOVASCULAR DRUGS AND THERAPY
    31. Cannon, CP
      Overcoming thrombolytic resistance - Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    32. Neuhaus, KL; Molhoek, GP; Zeymer, U; Tebbe, U; Wegscheider, K; Schroder, R; Camez, A; Laarman, GJ; Grollier, GR; Lok, DJA; Kuckuck, H; Lazarus, P
      Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    33. Aviles, FF
      Editorial comment. Infarct-related artery after thrombolysis: to see or not to see?

      REVISTA ESPANOLA DE CARDIOLOGIA
    34. Aviles, FF; Galan, LDF; Duran, JM; Gimeno, F; Ramos, B; Alonso, JJ; Garcimartin, I
      Acute coronary syndromes, role of angioplasty in the stent-era

      REVISTA ESPANOLA DE CARDIOLOGIA
    35. Williams, MJA; Stewart, RAH
      Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    36. Branzi, A; Melandri, G; Semprini, F; Descovich, B; Nanni, S; Cervi, V
      Long-term arterial patency after coronary reperfusion

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    37. Takazoe, K; Ogawa, H; Yasue, H; Sakamoto, T; Oshima, S; Arai, H; Moriyama, Y; Shimomura, H; Hirai, N; Kaikita, K; Soejima, H; Misumi, K; Hosoda, K
      Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction

      THROMBOSIS RESEARCH
    38. Oshima, S; Saito, T; Nakamura, S; Noda, K; Date, H; Hokimoto, S; Taniguchi, I; Yamamoto, N
      Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    39. Grines, CL; Cox, DA; Stone, GW; Garcia, E; Mattos, LA; Giambartolomei, A; Brodie, BR; Madonna, O; Eijgelshoven, M; Lansky, AJ; O'Neill, WW; Morice, MC
      Coronary angioplasty with or without stent implantation for acute myocardial infarction

      NEW ENGLAND JOURNAL OF MEDICINE
    40. Hansen, PS; Rasmussen, HH; Vinen, J; Nelson, GIC
      A primary stenting strategy as an alternative to fibrinolytic therapy in acute myocardial infarction - An analysis of results in hospital and at 6 weeks and 6 months

      MEDICAL JOURNAL OF AUSTRALIA
    41. Steinmetzer, T; Zhu, BY; Konishi, Y
      Potent bivalent thrombin inhibitors: Replacement of the scissile peptide bond at P-1-P-1 ' with arginyl ketomethylene isosteres

      JOURNAL OF MEDICINAL CHEMISTRY
    42. Antman, EM; Giugliano, RP; Gibson, CM; McCabe, CH; Coussement, P; Kleiman, NS; Vahanian, A; Adgey, AAJ; Menown, I; Rupprecht, HJ; Van der Wieken, R; Ducas, J; Scherer, J; Anderson, K; Van de Werf, F; Braunwald, E
      Abciximab facilitates the rate and extent of thrombolysis - Results of thethrombolysis in myocardial infarction (TIMI) 14 trial

      CIRCULATION
    43. Veen, G; de Boer, MJ; Zijlstra, F; Verheugt, FWA
      Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial)

      AMERICAN JOURNAL OF CARDIOLOGY
    44. URIUDA Y; WANG QD; HATORI N; NORDLANDER R; SJOQUIST PO; MATTSSON C; RYDEN L
      CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/

      Journal of pharmacological and toxicological methods
    45. HELFT G; BARA L; BLOCH MF; SAMAMA MM
      COMPARATIVE TIME-COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUSES AND INFUSION OF STAPHYLOKINASE AND TISSUE-PLASMINOGEN ACTIVATOR IN ARABBIT ARTERIAL THROMBOSIS MODEL

      Blood coagulation & fibrinolysis
    46. BAR FW; MEYER J; BOLAND J; BETRIU A; ARTMEYER B; CHARBONNIER B; MICHELS HR; TEBBE U; SPIECKER M; VERMEER F; VONFISENNE MJM; HOPKINS GR; BARTH H
      BOLUS ADMINISTRATION OF SARUPLASE IN EUROPE (BASE), A PILOT-STUDY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Journal of thrombosis and thrombolysis
    47. JANG IK; GIUGLIANO RP; MASSEY TJ; SCHWARZ RP
      A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY

      Journal of thrombosis and thrombolysis
    48. SALVIONI A; PEREGO GB; MARENZI G; GALLI S; ASSANELLI E; GUAZZI MD
      PLATELET ACTIVITY IN THE EARLY-STAGE OF ACUTE MYOCARDIAL-INFARCTION -RELATION TO TIME OF PRESENTATION, TREATMENT WITH EITHER TISSUE-PLASMINOGEN ACTIVATOR OR STREPTOKINASE AND CYCLOOXYGENASE INHIBITION

      Journal of thrombosis and thrombolysis
    49. DZAVIK V; CARERE RG; TEO KK; KNUDTSON ML; MARQUIS JF; BULLER CE
      AN OPEN DESIGN, MULTICENTER, RANDOMIZED TRIAL OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS STENTING, WITH A HEPARIN-COATED STENT, OF TOTALLY OCCLUDED CORONARY-ARTERIES - RATIONALE, TRIAL DESIGN ANDBASE-LINE PATIENT CHARACTERISTICS

      Canadian journal of cardiology
    50. GURBEL PA; SEREBRUANY VL; SHUSTOV AR; BAHR RD; CARPO C; OHMAN EA; TOPOL EJ
      EFFECTS OF RETEPLASE AND ALTEPLASE ON PLATELET-AGGREGATION AND MAJOR RECEPTOR EXPRESSION DURING THE FIRST 24 HOURS OF ACUTE MYOCARDIAL-INFARCTION TREATMENT

      Journal of the American College of Cardiology
    51. LI A; WUN TC
      PROTEOLYSIS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) BY PLASMIN - EFFECT ON TFPI ACTIVITY

      Thrombosis and haemostasis
    52. DESCHENES I; FINKLE CD; WINOCOUR PD
      EFFECTIVE USE OF BCH-2763, A NEW POTENT INJECTABLE DIRECT THROMBIN INHIBITOR, IN COMBINATION WITH TISSUE-PLASMINOGEN ACTIVATOR (TPA) IN A RAT ARTERIAL THROMBOLYSIS MODEL

      Thrombosis and haemostasis
    53. KAWASAKI T; SATO K; HIRAYAMA F; KOSHIO H; TANIUCHI Y; MATSUMOTO Y
      EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS

      Thrombosis and haemostasis
    54. Chicaud, P; Rademakers, JR; Millet, J
      The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat

      HAEMOSTASIS
    55. STRECKER EPK; GOTTMANN D; BOOS IBL; VETTER S
      LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN) REDUCES THE INCIDENCE OF FEMOROPOPLITEAL IN-STENT STENOSIS - PRELIMINARY-RESULTS OF AN ONGOING STUDY

      Cardiovascular and interventional radiology
    56. DAVIES CH; ORMEROD OJM
      FAILED CORONARY THROMBOLYSIS

      Lancet
    57. YAMASHITA T; TSUDA Y; KONISHI Y; OKADA Y; MATSUOKA A; GIDDINGS JC; YAMAMOTO J
      THE ANTITHROMBOTIC EFFECT OF POTENT BIFUNCTIONAL THROMBIN INHIBITORS BASED ON HIRUDIN SEQUENCE, P551 AND P532, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS

      Thrombosis research
    58. OGATA N; OGAWA H; OGATA Y; NUMATA Y; MORIGAMI Y; SUEFUJI H; SOEJIMA H; SAKAMOTO T; YASUE H
      COMPARISON OF THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE SUN9216) AND RECOMBINANT TPA (ALTEPLASE) FOR ACUTE MYOCARDIAL-INFARCTION/

      Japanese Circulation Journal
    59. MURPHY NP; PRATICO D; FITZGERALD DJ
      FUNCTIONAL RELEVANCE OF THE EXPRESSION OF LIGAND-INDUCED BINDING-SITES IN THE RESPONSE TO PLATELET GP LLB LLLA ANTAGONISTS IN-VIVO/

      The Journal of pharmacology and experimental therapeutics
    60. ZUCKER TP; BONISCH D; MUCK S; WEBER AA; BRETSCHNEIDER E; GLUSA E; SCHROR K
      THROMBIN-INDUCED MITOGENESIS IN CORONARY-ARTERY SMOOTH-MUSCLE CELLS IS POTENTIATED BY THROMBOXANE A(2) AND INVOLVES UP-REGULATION OF THROMBOXANE RECEPTOR MESSENGER-RNA

      Circulation
    61. SMALLING RW; ANDERSON HV
      PATHOPHYSIOLOGICAL INSIGHT INTO THE POSSIBLE OPTIMAL THERAPIES FOR ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA

      Circulation
    62. VANBELLE E; LABLANCHE JM; BAUTERS C; RENAUD N; MCFADDEN EP; BERTRAND ME
      CORONARY ANGIOSCOPIC FINDINGS IN THE INFARCT-RELATED VESSEL WITHIN 1 MONTH OF ACUTE MYOCARDIAL-INFARCTION - NATURAL-HISTORY AND THE EFFECT OF THROMBOLYSIS

      Circulation
    63. Horie, H; Takahashi, M; Minai, K; Izumi, M; Takaoka, A; Nozawa, M; Yokohama, H; Fujita, T; Sakamoto, T; Kito, O; Okamura, H; Kinoshita, M
      Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty

      CIRCULATION
    64. BERRY CN; LUNVEN C; LECHAIRE I; GIRARDOT C; OCONNOR SE
      ANTITHROMBOTIC ACTIVITY OF A MONOCLONAL-ANTIBODY INDUCING THE SUBSTRATE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS

      British Journal of Pharmacology
    65. FRENCH JK; ELLIS CJ; WEBBER BJ; WILLIAMS BF; AMOS DJ; RAMANATHAN K; WHITLOCK RML; WHITE HD
      ABNORMAL CORONARY FLOW IN INFARCT ARTERIES 1 YEAR AFTER MYOCARDIAL-INFARCTION IS PREDICTED AT 4 WEEKS BY CORRECTED THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) FRAME COUNT AND STENOSIS SEVERITY

      The American journal of cardiology
    66. BRIEGER DB; MAK KH; WHITE HD; KLEIMAN NS; MILLER DP; VAHANIAN A; ROSS AM; CALIFF RM; TOPOL EJ
      BENEFIT OF EARLY SUSTAINED REPERFUSION IN PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION (THE GUSTO-I TRIAL)

      The American journal of cardiology
    67. TAN WA; MOLITERNO DJ
      TIMI FLOW AND SURROGATE END-POINTS - WHAT YOU SEE IS NOT ALWAYS WHAT YOU GET

      The American heart journal
    68. VANTHOF AWJ; DEBOER MJ; SURYAPRANATA H; HOORNTJE JCA; ZIJLSTRA F
      INCIDENCE AND PREDICTORS OF RESTENOSIS AFTER SUCCESSFUL PRIMARY CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - THE IMPORTANCE OF AGE AND PROCEDURAL RESULT

      The American heart journal
    69. KAWANO K; AOKI I; AOKI N; HOMORI M; MAKI A; HIOKI Y; HASUMURA Y; TERANO A; ARAI T; MIZUNO H; ISHIKAWA K
      HUMAN PLATELET ACTIVATION BY THROMBOLYTIC AGENTS - EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE ON PLATELET SURFACE P-SELECTIN EXPRESSION

      The American heart journal
    70. MATTSSON C; BJORKMAN JA; ULVINGE JC
      MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS

      Fibrinolysis & proteolysis
    71. COMMERFORD PJ
      HEPARIN AFTER ACUTE MYOCARDIAL-INFARCTION

      Cardiovascular drugs and therapy
    72. WILLIAMS MJA; MORISON IM; PARKER JH; STEWART RAH
      PROGRESSION OF THE CULPRIT LESION IN UNSTABLE CORONARY-ARTERY DISEASEWITH WARFARIN AND ASPIRIN VERSUS ASPIRIN ALONE - PRELIMINARY-STUDY

      Journal of the American College of Cardiology
    73. ZIJLSTRA F; BEUKEMA WP; VANTHOF AWJ; LIEM A; REIFFERS S; HOORNTJE JCA; SURYAPRANATA H; DEBOER MJ
      RANDOMIZED COMPARISON OF PRIMARY CORONARY ANGIOPLASTY WITH THROMBOLYTIC THERAPY IN LOW-RISK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Journal of the American College of Cardiology
    74. LEADLEY RJ; KASIEWSKI CJ; BOSTWICK JS; BENTLEY R; MCVEY MJ; WHITE FJ; PERRONE MH; DUNWIDDIE CT
      COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY

      Thrombosis and haemostasis
    75. ALCIBAR J; GOCHI R; ONATE A; BARRENETXEA JI; RUMOROSO JR; SALAZAR H; JIMENEZ A; RODRIGO D; GONZALEZLIEBANA J; PENA N; CEMBELLIN JC
      LATE REOPENING OF A PATENT DUCTUS-ARTERIO SUS AFTER COMPLETE CLOSURE WITH THE RASHKINDS PROSTHESIS - SUSPECT OF A TRAUMATIC ORIGIN

      Revista espanola de cardiologia
    76. LABHASETWAR V; SONG CX; LEVY RJ
      NANOPARTICLE DRUG-DELIVERY SYSTEM FOR RESTENOSIS

      Advanced drug delivery reviews
    77. BECKER RC
      DYNAMICS OF CORONARY THROMBOLYSIS AND REOCCLUSION

      Clinical cardiology
    78. REBELLO SS; MILLER BV; BASLER GC; LUCCHESI BR
      CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY

      Journal of cardiovascular pharmacology
    79. SANCHEZ EF; BUSH LR; SWENSON S; MARKLAND FS
      CHIMERIC FIBROLASE - COVALENT ATTACHMENT OF AN RGD-LIKE PEPTIDE TO CREATE A POTENTIALLY MORE EFFECTIVE THROMBOLYTIC AGENT

      Thrombosis research
    80. YANG LH; FAREED J
      VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE

      Thrombosis research
    81. YAMASHITA T; TSUJI T; MATSUOKA A; GIDDINGS JC; YAMAMOTO J
      THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW-MOLECULAR-WEIGHT HUMAN FACTOR XA INHIBITOR DX-9065A, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS

      Thrombosis research
    82. REBELLO SS; DRISCOLL EM; LUCCHESI BR
      TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/

      Stroke
    83. MOUSA SA; MU DX; LUCCHESI BR
      PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/

      Stroke
    84. PRATICO D; MURPHY NP; FITZGERALD DJ
      INTERACTION OF A THROMBIN INHIBITOR AND A PLATELET GP IIB IIIA ANTAGONIST IN-VIVO - EVIDENCE THAT THROMBIN MEDIATES PLATELET-AGGREGATION AND SUBSEQUENT THROMBOXANE A(2) FORMATION DURING CORONARY THROMBOLYSIS/

      The Journal of pharmacology and experimental therapeutics
    85. BIRNBAUM Y; HALE SL; KLONER RA
      CHANGES IN R-WAVE AMPLITUDE - ECG-DIFFERENTIATION BETWEEN EPISODES OFREOCCLUSION AND REPERFUSION ASSOCIATED WITH ST-SEGMENT ELEVATION

      Journal of electrocardiology
    86. FRIEDERICH PW; LEVI M; BIEMOND BJ; CHARLTON P; TEMPLETON D; VANZONNEVELD AJ; BEVAN P; PANNEKOEK H; TENCATE JW
      NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS

      Circulation
    87. BODE C; HANSON SR; SCHMEDTJE JF; HABER E; MEHWALD P; KELLY AB; HARKER LA; RUNGE MS
      ANTITHROMBOTIC POTENCY OF HIRUDIN IS INCREASED IN NONHUMAN-PRIMATES BY FIBRIN TARGETING

      Circulation
    88. OHMAN EM; KLEIMAN NS; GACIOCH G; WORLEY SJ; NAVETTA FI; TALLEY JD; ANDERSON HV; ELLIS SG; COHEN MD; SPRIGGS D; MILLER M; KEREIAKES D; YAKUBOV S; KITT MM; SIGMON KN; CALIFF RM; KRUCOFF MW; TOPOL EJ
      COMBINED ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR AND PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN RECEPTOR BLOCKADE WITH INTEGRIN IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL/

      Circulation
    89. VANTHOF AW; ZIJLSTRA F; DEBOER MJ; LIEM AL; HOORNTJE JC; SURYAPRANATA H
      PATENCY AND REINFARCTION IN LATE-ENTRY MYOCARDIAL INFARCT PATIENTS TREATED WITH REPERFUSION THERAPY

      Angiology
    90. WARD SR; SUTTON JM; PIEPER KS; SCHWAIGER M; CALIFF RM; TOPOL EJ
      EFFECTS OF THROMBOLYTIC REGIMEN, EARLY CATHETERIZATION, AND PREDISCHARGE ANGIOGRAPHIC VARIABLES ON 6-WEEK LEFT-VENTRICULAR FUNCTION

      The American journal of cardiology
    91. DREW BJ; ADAMS MG; PELTER MM; WUNG SF; CALDWELL MA
      COMPARISON OF STANDARD AND DERIVED 12-LEAD ELECTROCARDIOGRAMS FOR DIAGNOSIS OF CORONARY ANGIOPLASTY-INDUCED MYOCARDIAL-ISCHEMIA

      The American journal of cardiology
    92. KURISU S; SATO H; TATEISHI H; KAWAGOE T; ISHIHARA M; SHIMATANI Y; SAKAI K; UEDA K; MATSUURA H
      DIRECTIONAL CORONARY ATHERECTOMY FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION

      The American heart journal
    93. FATHORDOUBADI F; HUEHNS TY; ALMOHAMMAD A; BEATT KJ
      SIGNIFICANCE OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION SCORING SYSTEM IN ASSESSING INFARCT-RELATED ARTERY REPERFUSION AND MORTALITY-RATES AFTER ACUTE MYOCARDIAL-INFARCTION

      The American heart journal
    94. EMMERICH K; KLOS M; ULBRICHT LJ; KRAKAU I; PROBST H
      TREATMENT OF MYOCARDIAL-INFARCTION BY PTCA WITHIN 12 TO 24 HOURS AFTER ONSET OF PAIN

      Deutsche Medizinische Wochenschrift
    95. SEREBRUANY VL; HERZOG WR; GURBEL PA
      SERIAL CHANGES OF NATURAL ANTITHROMBOTICS DURING MYOCARDIAL ISCHEMIA-REPERFUSION IN SWINE - EFFECTS OF MAGNESIUM, DILTIAZEM, AND A NOVEL MAC-1 INHIBITOR

      Blood coagulation & fibrinolysis
    96. YUSUF SW; SANDERSON H; HEPTINSTALL S; NURDEN AT; WENHAM PW; HOPKINSON BR
      ADP-INDUCED P-SELECTIN EXPRESSION ON PLATELETS AS A PREDICTOR OF SUCCESSFUL THROMBOLYSIS

      Blood coagulation & fibrinolysis
    97. NICOLINI FA; LEE P; MALYCKY JL; LEFKOVITS J; KOTTKEMARCHANT K; PLOW EF; TOPOL EJ
      SELECTIVE-INHIBITION OF FACTOR XA DURING THROMBOLYTIC THERAPY MARKEDLY IMPROVES CORONARY-ARTERY PATENCY IN A CANINE MODEL OF CORONARY-THROMBOSIS

      Blood coagulation & fibrinolysis
    98. BLEICH SD
      ANGIOGRAPHIC STUDIES DEMONSTRATING THE NEED FOR CONJUNCTIVE ANTICOAGULATION

      Coronary artery disease
    99. FITZGERALD D; MURPHY N
      ARGATROBAN - A SYNTHETIC THROMBIN INHIBITOR OF LOW RELATIVE MOLECULAR-MASS

      Coronary artery disease
    100. KORNOWSKI R; ELDOR A; WERBER MM; EZOV N; ZWANG E; NIMROD A; CHERNINE A; FINKELSTEIN A; PANET A; LANIADO S; KEREN G
      ENHANCEMENT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THROMBOLYSIS WITH A SELECTIVE FACTOR XA INHIBITOR DERIVED FROM THE LEECH HIRUDO-MEDICINALIS - COMPARISON WITH HEPARIN AND HIRUDIN IN A RABBIT THROMBOSIS MODEL

      Coronary artery disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:00:18